德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

未开盘 03-24 16:08:08

3.040

-0.040

-1.30%

最高3.120	最低2.990	成交量58.15万
今开3.040	昨收3.080	日振幅4.22%
总市值20.52亿	流通市值20.52亿	总股本6.75亿
成交额177.29万	换手率0.09%	流通股本6.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":3.04,"timestamp":1679645288023,"preClose":3.08,"halted":0,"volume":581500,"delay":0,"floatShares":674888744,"shares":674888744,"eps":-1.1986853,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.04,"latestTime":"03-24 16:08:08","open":3.04,"high":3.12,"low":2.99,"amount":1772911,"amplitude":0.042208,"askPrice":3.05,"askSize":2000,"bidPrice":3.04,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.0421308268900176,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1679880600000},"adr":0,"listingDate":1605801600000,"adjPreClose":3.08,"volumeRatio":0.4858384159037025,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2321612907","title":"德琪医药-B股价活跃 临近尾盘升近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2321612907","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2321612907?lang=zh_CN&edition=full","pubTime":"2023-03-21 15:49","pubTimestamp":1679384995,"startTime":"0","endTime":"0","summary":"德琪医药-B相对活跃，临近尾盘上升6.79%，现报2.99港元，成交额315.075万港元。　　3月20日，德琪医药宣布，公司将在下月举办的2023年美国癌症研究协会年会上展示五篇摘要壁报，包括ATG-008治疗HBV+且至少接受过一线系统性疗法的晚期肝细胞癌患者的开放性II期临床试验结果和ATG-031、ATG-037、ATG-017和ATG-034的临床前研究数据。炒股开户享福利，送投顾服务60天体验权，一对一指导服务！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-21/doc-imymrnuv9848750.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-21/doc-imymrnuv9848750.shtml","is_publish_highlight":false},{"id":"2321614049","title":"港股异动 | 德琪医药-B(06996)升7% 拟发布ATG-008治疗HCC II期临床研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2321614049","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2321614049?lang=zh_CN&edition=full","pubTime":"2023-03-21 15:36","pubTimestamp":1679384213,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B相对活跃，临近尾盘升约7%。公司拟于下月发布核心产品之一ATG-008治疗HBV+且至少接受过一线系统性疗法的晚期肝细胞癌患者的开放性II期临床试验结果。截至发稿，德琪医药涨6.79%，报2.99港元，市值20.18亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/895501.html","is_publish_highlight":false},{"id":"2321162936","title":"港股异动 | 德琪医药-B盘中涨超6%  再携五项研究成果入选AACR 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2321162936","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2321162936?lang=zh_CN&edition=full","pubTime":"2023-03-21 14:25","pubTimestamp":1679379936,"startTime":"0","endTime":"0","summary":"格隆汇3月21日丨德琪医药-B盘中涨超6%。德琪医药昨日宣布将于4月14日至19日在2023年美国癌症研究协会年会上展示五篇摘要壁报。五篇壁报将介绍公司的临床及临床前管线进展，包括ATG-008 的临床研究数据和ATG-031 、ATG-037 、ATG-017 和ATG-034  的临床前研究数据。据悉公司已在美国及多个亚太市场获得28个临床批件  ，并递交了9个新药上市申请 。目前，希维奥已获得中国大陆、中国台湾、韩国、新加坡和澳大利亚的新药上市批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321142546841c1aeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321142546841c1aeb&s=b","is_publish_highlight":false},{"id":"2319603381","title":"德琪医药-B盘中异动 股价大跌5.06%报3.001港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2319603381","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2319603381?lang=zh_CN&edition=full","pubTime":"2023-03-16 14:16","pubTimestamp":1678947367,"startTime":"0","endTime":"0","summary":"2023年03月16日下午盘14时16分，德琪医药-B股票出现异动，股价大幅下挫5.06%。截至发稿，该股报3.001港元/股，成交量61.75万股，换手率0.09%，振幅6.01%。资金方面，该股资金流入56.9145万港元，流出119.52万港元。德琪医药-B股票所在的药品行业中，整体涨幅为0.15%。该公司主要在亚太地区开展业务。消息层面，截至14时16分，德琪医药-B股票正面舆情新闻比例77.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303161416088061c6c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303161416088061c6c5&s=b","is_publish_highlight":false},{"id":"2319621855","title":"德琪医药-B(06996.HK)拟3月28日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2319621855","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2319621855?lang=zh_CN&edition=full","pubTime":"2023-03-15 08:02","pubTimestamp":1678838549,"startTime":"0","endTime":"0","summary":"格隆汇3月15日丨德琪医药-B(06996.HK)发布公告，公司将于2023年3月28日(星期二)举行董事会会议，藉以(其中包括)考虑并批准公司及其附属公司截至2022年12月31日止年度业绩及其发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031508030484199c82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031508030484199c82&s=b","is_publish_highlight":false},{"id":"2319489980","title":"德琪医药－Ｂ(06996.HK)获内地批准治疗实体瘤药物I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2319489980","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319489980?lang=zh_CN&edition=full","pubTime":"2023-03-14 08:34","pubTimestamp":1678754040,"startTime":"0","endTime":"0","summary":"德琪医药－Ｂ公布，国家药监局已批准ATG-022用于治疗晚期及转移性实体瘤的I期临床试验。该研究的主要目的为评估ATG-022单药的安全性及耐受性，以确认ATG-022的生物有效剂量、最大耐受剂量和II期试验的使用剂量。ATG-022是一种靶向Claudin 18.2的抗体药物偶联物。Claudin为通常在细胞间紧密连接内表达以形成调节细胞渗透性的屏障的细胞黏附分子。在癌症中，Claudin会因为细胞极性改变而在细胞表面表达。Claudin 18.2异构体在多种原发性恶性肿瘤中过度表达。沽空资料截至 2023-03-13 16:25。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210304121502059_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210304121502059_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1251306/latest-news/HK6","is_publish_highlight":false},{"id":"2319039926","title":"超20家上市公司集体回应“硅谷银行存款占比”：普遍不到5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319039926","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2319039926?lang=zh_CN&edition=full","pubTime":"2023-03-13 14:40","pubTimestamp":1678689630,"startTime":"0","endTime":"0","summary":"颇受初创企业青睐的美国硅谷银行轰然倒闭，多家上市公司纷纷回应。　　3月12日至3月13日，对于美国风投型银行硅谷银行倒闭一事，截至发稿，至少有23家上市公司在交易所、微信公众号、互动平台公开披露了公司在硅谷银行存款情况。　　九安医疗称，截至2023年3月10日，公司及子公司在硅谷银行的存款金额，占公司现金类资产及金融资产总额的比例约5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/jjxw/2023-03-13/doc-imyktfsz5504658.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2023-03-13/doc-imyktfsz5504658.shtml","is_publish_highlight":false},{"id":"2319208489","title":"德琪医药-B盘中异动 急速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319208489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2319208489?lang=zh_CN&edition=full","pubTime":"2023-03-13 11:05","pubTimestamp":1678676750,"startTime":"0","endTime":"0","summary":"2023年03月13日早盘11时05分，德琪医药-B股票出现异动，股价快速下跌5.31%。截至发稿，该股报3.050港元/股，成交量80.95万股，换手率0.12%，振幅6.52%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。德琪医药-B股票所在的药品行业中，整体涨幅为2.19%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230313110550846dd7d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230313110550846dd7d6&s=b","is_publish_highlight":false},{"id":"2319081020","title":"德琪医药－Ｂ(06996)股价下跌5.28%，现价港币$3.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2319081020","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319081020?lang=zh_CN&edition=full","pubTime":"2023-03-13 11:05","pubTimestamp":1678676700,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药－Ｂ(06996) 股价在上午11:05比前收市价下跌5.28%，现股价为港币$3.05。至目前为止，今日最高价为$3.26，而最低价为$3.05。总成交量为80.95万股，总成交金额为港币$254.43万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2303131293/aamm-all-category","is_publish_highlight":false},{"id":"2319706913","title":"德琪医药：未在硅谷银行持有现金存款或信贷额度","url":"https://stock-news.laohu8.com/highlight/detail?id=2319706913","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2319706913?lang=zh_CN&edition=full","pubTime":"2023-03-13 07:01","pubTimestamp":1678662061,"startTime":"0","endTime":"0","summary":"德琪医药3月13日早间在港交所公告，公司获悉，媒体报道称硅谷银行（SVB）已被加州金融保护和创新部关闭，该部门任命美国联邦存款保险公司（FDIC）为接管方。公司谨此告知其股东及潜在投资者，集团并未在SVB持有现金存款或信贷额度，与SVB亦无其他业务关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031307010283536717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031307010283536717&s=b","is_publish_highlight":false},{"id":"2319705687","title":"德琪医药-B(06996)：并未在SVB持有现金存款或信贷额度，与SVB亦无其他业务关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2319705687","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2319705687?lang=zh_CN&edition=full","pubTime":"2023-03-13 06:32","pubTimestamp":1678660326,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，公司获悉，媒体报道称Silicon Valley Bank(SVB)已被加州金融保护和创新部关闭，该部门任命Federal Deposit Insurance Corporation为接管方。公司谨此告知其股东及潜在投资者，集团并未在SVB持有现金存款或信贷额度，与SVB亦无其他业务关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/890521.html","is_publish_highlight":false},{"id":"2317113483","title":"德琪医药-B盘中异动 大幅下跌5.05%报3.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2317113483","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2317113483?lang=zh_CN&edition=full","pubTime":"2023-03-06 10:26","pubTimestamp":1678069576,"startTime":"0","endTime":"0","summary":"2023年03月06日早盘10时26分，德琪医药-B股票出现波动，股价大幅跳水5.05%。截至发稿，该股报3.780港元/股，成交量65.95万股，换手率0.10%，振幅5.53%。德琪医药-B股票所在的药品行业中，整体跌幅为0.47%。其相关个股中，艾美疫苗、满贯集团、吉林长龙药业涨幅较大，振幅较大的相关个股有艾美疫苗、前海健康、满贯集团，振幅分别为11.35%、6.67%、5.95%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230306102616846dbe75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230306102616846dbe75&s=b","is_publish_highlight":false},{"id":"2312276153","title":"德琪医药-B盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2312276153","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2312276153?lang=zh_CN&edition=full","pubTime":"2023-02-20 16:03","pubTimestamp":1676880220,"startTime":"0","endTime":"0","summary":"2023年02月20日临近收盘16时03分，德琪医药-B股票出现异动，股价快速上涨5.27%。截至发稿，该股报4.611港元/股，成交量80.15万股，换手率0.12%，振幅4.57%。德琪医药-B股票所在的药品行业中，整体涨幅为0.58%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022016034080616330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022016034080616330&s=b","is_publish_highlight":false},{"id":"2311142176","title":"德琪医药-B盘中异动 早盘快速下挫5.10%报4.470港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2311142176","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311142176?lang=zh_CN&edition=full","pubTime":"2023-02-15 09:56","pubTimestamp":1676426184,"startTime":"0","endTime":"0","summary":"2023年02月15日早盘09时56分，德琪医药-B股票出现异动，股价快速跳水5.10%。截至发稿，该股报4.470港元/股，成交量69.75万股，换手率0.10%，振幅6.79%。资金方面，该股资金流入92.3545万港元，流出160.66万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.37%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023021509562482b68de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023021509562482b68de5&s=b","is_publish_highlight":false},{"id":"2311670159","title":"德琪医药-B盘中异动 临近收盘股价大跌5.07%报4.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2311670159","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311670159?lang=zh_CN&edition=full","pubTime":"2023-02-14 15:50","pubTimestamp":1676361042,"startTime":"0","endTime":"0","summary":"2023年02月14日临近收盘15时50分，德琪医药-B股票出现波动，股价快速下挫5.07%。截至发稿，该股报4.680港元/股，成交量126.85万股，换手率0.19%，振幅4.26%。德琪医药-B股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，兴科蓉医药、泰凌医药、开拓药业-B涨幅较大，振幅较大的相关个股有兴科蓉医药、三爱健康集团、思派健康，振幅分别为22.50%、14.13%、11.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214155042846d7ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214155042846d7ccf&s=b","is_publish_highlight":false},{"id":"2311104159","title":"德琪医药－Ｂ(06996)股价下跌5.071%，现价港币$4.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2311104159","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2311104159?lang=zh_CN&edition=full","pubTime":"2023-02-14 15:50","pubTimestamp":1676361000,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药－Ｂ(06996) 股价在下午03:50比前收市价下跌5.071%，现股价为港币$4.68。至目前为止，今日最高价为$4.89，而最低价为$4.68。总成交量为126.75万股，总成交金额为港币$605.632万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2302141151/aamm-all-category","is_publish_highlight":false},{"id":"2310361943","title":"德琪医药-B盘中异动 临近收盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2310361943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2310361943?lang=zh_CN&edition=full","pubTime":"2023-02-10 15:43","pubTimestamp":1676015002,"startTime":"0","endTime":"0","summary":"2023年02月10日临近收盘15时43分，德琪医药-B股票出现波动，股价急速下跌5.03%。德琪医药-B股票所在的药品行业中，整体跌幅为0.74%。其相关个股中，中生联合、国药控股、前海健康涨幅较大，振幅较大的相关个股有三爱健康集团、华控康泰、衍生集团，振幅分别为14.29%、11.54%、10.59%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230210154322846d7380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230210154322846d7380&s=b","is_publish_highlight":false},{"id":"2308888420","title":"德琪医药-B盘中异动 早盘大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2308888420","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2308888420?lang=zh_CN&edition=full","pubTime":"2023-02-03 09:46","pubTimestamp":1675388805,"startTime":"0","endTime":"0","summary":"2023年02月03日早盘09时46分，德琪医药-B股票出现异动，股价快速拉升5.08%。截至发稿，该股报6.000港元/股，成交量81.7万股，换手率0.12%，振幅5.08%。德琪医药-B股票所在的药品行业中，整体涨幅为0.07%。其相关个股中，开拓药业-B、朗生医药、德琪医药-B涨幅较大，振幅较大的相关个股有开拓药业-B、翰森制药、康龙化成，振幅分别为4.35%、4.02%、3.80%。消息层面，截至09时46分，德琪医药-B股票正面舆情新闻比例26.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023020309464580612631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023020309464580612631&s=b","is_publish_highlight":false},{"id":"2308709632","title":"德琪医药-B(06996.HK)涨超7%，截至发稿，涨6.17%，报5.85港元，成交额393.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2308709632","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2308709632?lang=zh_CN&edition=full","pubTime":"2023-02-02 09:50","pubTimestamp":1675302639,"startTime":"0","endTime":"0","summary":"截至2023年2月1日收盘，德琪医药-B报收于5.51港元，上涨6.78%，换手率0.32%，成交量215.35万股，成交额1158.27万港元。投行对该股的评级以买入为主，近90天内共有1家投行给出买入评级，近90天的目标均价为8.18港元。国元国际最新一份研报给予德琪医药-B买入评级，目标价8.18港元。机构评级详情见下表：德琪医药-B港股市值37.19亿港元，在生物制品Ⅱ行业中排名第30。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023020200003684.shtml","is_publish_highlight":false},{"id":"2308436095","title":"港股异动 | 德琪医药-B(06996)涨超7% ATG-022用于治疗晚期或转移性实体瘤患者的首次临床试验已获准在澳大利亚开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2308436095","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2308436095?lang=zh_CN&edition=full","pubTime":"2023-02-02 09:44","pubTimestamp":1675302272,"startTime":"0","endTime":"0","summary":"德琪医药-B(06996)涨超7%，截至发稿，涨6.17%，报5.85港元，成交额393.83万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20230202/20230202094516_56080.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230202/20230202094516_56080.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/870237.html","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":-0.2847},{"period":"3month","weight":-0.4016},{"period":"6month","weight":-0.0675},{"period":"1year","weight":-0.5742},{"period":"ytd","weight":-0.4097}],"websiteUrl":"http://www.antengene.com","compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0165},{"period":"6month","weight":0.1105},{"period":"1year","weight":-0.0925},{"period":"ytd","weight":0.0068}],"name":"德琪医药-B","description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","exchange":"SEHK","nameEN":"ANTENGENE-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.12.1","shortVersion":"4.12.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}